CRIS Current Research Information System

STAGNI, FIORENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.325
AS - Asia 1.652
EU - Europa 1.570
AF - Africa 169
SA - Sud America 90
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.301
IT - Italia 601
SG - Singapore 598
CN - Cina 506
GB - Regno Unito 266
VN - Vietnam 237
DE - Germania 208
HK - Hong Kong 134
SE - Svezia 106
NL - Olanda 75
IN - India 70
BR - Brasile 67
CI - Costa d'Avorio 61
TG - Togo 58
IE - Irlanda 51
FR - Francia 49
RU - Federazione Russa 49
KR - Corea 41
BG - Bulgaria 27
CH - Svizzera 24
JO - Giordania 23
BE - Belgio 22
ZA - Sudafrica 22
FI - Finlandia 20
SC - Seychelles 19
UA - Ucraina 17
EE - Estonia 16
AR - Argentina 14
JP - Giappone 14
CA - Canada 13
AT - Austria 11
MX - Messico 10
ID - Indonesia 8
PL - Polonia 7
GR - Grecia 5
LT - Lituania 5
NG - Nigeria 5
AU - Australia 4
CL - Cile 4
IR - Iran 4
BD - Bangladesh 3
EC - Ecuador 3
ES - Italia 3
RO - Romania 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
HU - Ungheria 2
IQ - Iraq 2
MY - Malesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
HR - Croazia 1
JM - Giamaica 1
MA - Marocco 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.811
Salva come PNG Salva come JPEG
Città #
Singapore 403
Chandler 258
Ashburn 250
Fairfield 237
Bologna 231
Southend 231
Hong Kong 133
Santa Clara 130
Houston 126
Hefei 121
Seattle 115
Wilmington 114
Ann Arbor 107
Woodbridge 96
Beijing 72
Cambridge 68
Abidjan 61
Princeton 60
Ho Chi Minh City 58
Lomé 58
Hanoi 57
Boardman 52
Dublin 51
Dong Ket 47
Frankfurt am Main 45
Seoul 41
Turin 41
Los Angeles 35
Redmond 33
Falls Church 29
Rimini 28
Sofia 27
Amman 23
Dallas 23
Milan 23
Bern 21
Brussels 21
Buffalo 21
Munich 21
Westminster 21
Nanjing 18
New York 16
Padova 16
Jinan 15
San Diego 15
Shenyang 15
Berlin 14
Bengaluru 12
Rome 12
Shanghai 12
Redondo Beach 11
Tianjin 11
Trento 11
Redwood City 10
Saint Petersburg 10
Tokyo 10
Changsha 9
Guangzhou 9
Hebei 9
Helsinki 9
Udine 9
Bolzano 8
Chicago 8
Florence 8
Meldola 8
São Paulo 8
Toronto 8
Vienna 8
Zhengzhou 8
Amsterdam 7
Bắc Ninh 7
Council Bluffs 7
Ha Long 7
London 7
Des Moines 6
Jakarta 6
Lappeenranta 6
Olalla 6
Portsmouth 6
Abeokuta 5
Cento 5
Da Nang 5
Falkenstein 5
Forlì 5
Mexico City 5
Nanchang 5
Naples 5
Paris 5
Parma 5
Ravenna 5
San Giorgio di Piano 5
The Dalles 5
Turku 5
Wuhan 5
Brooklyn 4
Castel Maggiore 4
Düsseldorf 4
Hải Dương 4
Ninh Bình 4
Norwalk 4
Totale 4.070
Salva come PNG Salva come JPEG
Nome #
Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome 278
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS 258
Impaired brain mitochondrial bioenergetics in the ts65dn mouse model of down syndrome is restored by neonatal treatment with the polyphenol 7,8-dihydroxyflavone 210
Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome 202
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 196
Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders 196
Abnormal development of the inferior temporal region in fetuses with Down Syndrome 193
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse 191
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 188
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 181
Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome? 178
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome 170
Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome 169
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 161
SNX27, a protein involved in down syndrome, regulates GPR17 trafficking and oligodendrocyte differentiation 157
Early appearance of dendritic alterations in neocortical pyramidal neurons of the Ts65Dn model of Down syndrome 154
Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome 152
Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome 152
Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome. 151
Neuroanatomical Alterations in Higher-Order Thalamic Nuclei of Fetuses With Down Syndrome 146
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome 142
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome 140
Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome 138
Effect of adolescent treatment with the flavonoid 7,8-DHF on brain wiring, synaptic plasticity and cognitive performance in a model of Down syndrome 137
Timing of therapies for downsyndrome: The sooner, the better 137
null 130
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. 130
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome. 129
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 117
Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model 116
Targeting APP/AICD in Down syndrome 109
The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives 106
Cellularity Defects Are Not Ubiquitous in the Brains of Fetuses With Down Syndrome 103
Dendritic phenotype and proliferation potency in the hippocampal dentate gyrus of the Ts66Yah model of Down syndrome 97
null 97
Epigallocatechin-3-gallate: Linking the neurogenesis, hippocampus, and Down syndrome 93
Neurogenesis impairment: An early developmental defect in Down syndrome 85
null 83
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. 77
Advocating for increased awareness and research on Down syndrome 58
“Administration of the BDNF mimetic 7,8-Dihydroxyflavone during adolescence rescues neuron maturation and improves hippocampus- dependent memory in the Ts65Dn mouse model of Down syndrome”. 19
“Il trattamento adolescenziale con il BDNF mimetico 7,8-diidrossiflavone influenza la metilazione del DNA nell'ippocampo del modello Ts65Dn di sindrome di Down” 12
“Early pharmacotherapies for the rescue of intellectual disability in Down syndrome” 12
“Adolescence represents an important window of opportunity for the rescue of dendritic pathology with a BDNF mimetic in a mouse model of Down syndrome” 11
“Trattamento adolescenziale con il BDNF mimetico 7,8- diidrossiflavone: una strategia utile per migliorare lo sviluppo della fascia dentata ippocampica nel modello Ts65Dn di sindrome di Down”. 6
“La somministrazione neonatale di astaxantina tramite nanoparticelle ha un effetto proproliferativo nel modello murino Ts65Dn” 6
“Is it possible to prevent or counteract Alzheimer’s disease in Down syndrome with molecules with antioxidant and anti-inflammatory properties?” 6
“Neonatal treatment with astaxanthin-loaded stealth lipid nanoparticles fosters hippocampal neurogenesis in a mouse model of Down syndrome” 5
“Analisi dell’espressione genica in ippocampi di topi Ts65Dn sottoposti a trattamento adolescenziale con il BDNF-mimetico 7,8 diidrossiflavone” 5
“Trattamento neonatale con astaxantina veicolata tramite nanoparticelle: effetti sullo sviluppo ippocampale e sullo stress ossidativo nel modello murino Ts65D” 5
“Effects of 7,8-dihydroxyflavone treatment on DNA methylation profiles of adolescent Ts65Dn mice hippocampus” 4
“Effects of neonatal treatment with astaxanthin-loaded stealth lipid nanoparticles on hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome” 4
“Il trattamento con il polifenolo Polidatina migliora lo sviluppo cerebrale e la memoria ippocampo-dipendente nel topo Ts65Dn, modello di sindrome di Down” 3
Totale 6.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021314 0 0 0 0 0 30 12 47 56 49 25 95
2021/2022584 33 27 25 15 68 42 55 35 26 37 110 111
2022/2023960 74 161 52 121 62 77 37 57 147 15 79 78
2023/2024284 21 46 17 29 15 55 3 5 3 21 41 28
2024/20251.218 76 88 98 85 179 50 131 66 37 96 106 206
2025/20261.418 311 223 203 237 340 104 0 0 0 0 0 0
Totale 6.005